Search research articles
Contact Us
Filters
Showing results (391-400 of 535) with videos related to
Page
of 54
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
M Montopoli, S Zumerle, R Vettor, et al.
JAMA
|
September 18, 1996
Career development for women in academic medicine: Multiple interventions in a department of medicine
L P Fried, C A Francomano, S M MacDonald, et al.
Cancers
|
October 17, 2020
Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). <i>Cancers</i> 2020, <i>12</i>, 176
Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 7, 2017
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells
Davide Genini, Lara Brambilla, Erik Laurini, et al.
Cancers
|
January 16, 2020
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)
Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Oncogene
|
June 27, 2012
Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression
N Longoni, P Kunderfranco, S Pellini, et al.
Cancer Research
|
May 20, 2016
Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer
Domenico Albino, Gianluca Civenni, Cecilia Dallavalle, et al.
Oncogene
|
August 1, 2017
Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
A Szymiczek, M Carbone, S Pastorino, et al.
Nucleic Acids Research
|
March 31, 2006
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy
Veronica Albertini, Aklank Jain, Sara Vignati, et al.
Nature Medicine
|
August 1, 1997
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
A De Luca, A Baldi, V Esposito, et al.
Page
of 54
Search research articles
Search
Showing results (391-400 of 535) with videos related to
Sort By:
Page
of 54
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
M Montopoli, S Zumerle, R Vettor, et al.
JAMA
|
September 18, 1996
Career development for women in academic medicine: Multiple interventions in a department of medicine
L P Fried, C A Francomano, S M MacDonald, et al.
Cancers
|
October 17, 2020
Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). <i>Cancers</i> 2020, <i>12</i>, 176
Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 7, 2017
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells
Davide Genini, Lara Brambilla, Erik Laurini, et al.
Cancers
|
January 16, 2020
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)
Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Oncogene
|
June 27, 2012
Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression
N Longoni, P Kunderfranco, S Pellini, et al.
Cancer Research
|
May 20, 2016
Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer
Domenico Albino, Gianluca Civenni, Cecilia Dallavalle, et al.
Oncogene
|
August 1, 2017
Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
A Szymiczek, M Carbone, S Pastorino, et al.
Nucleic Acids Research
|
March 31, 2006
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy
Veronica Albertini, Aklank Jain, Sara Vignati, et al.
Nature Medicine
|
August 1, 1997
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
A De Luca, A Baldi, V Esposito, et al.
Page
of 54